BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27926471)

  • 1. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
    Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
    Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
    World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
    Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
    PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
    Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and prognostic factors of anaplastic thyroid carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W; Yue Y; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival.
    Wächter S; Vorländer C; Schabram J; Mintziras I; Fülber I; Manoharan J; Holzer K; Bartsch DK; Maurer E
    Eur Arch Otorhinolaryngol; 2020 May; 277(5):1507-1514. PubMed ID: 32060602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
    Wei YC; Zhang D; Chai Y; Dong M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
    Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
    Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
    Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
    Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
    Prasongsook N; Kumar A; Chintakuntlawar AV; Foote RL; Kasperbauer J; Molina J; Garces Y; Ma D; Wittich MAN; Rubin J; Richardson R; Morris J; Hay I; Fatourechi V; McIver B; Ryder M; Thompson G; Grant C; Richards M; Sebo TJ; Rivera M; Suman V; Jenkins SM; Smallridge RC; Bible KC
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4506-4514. PubMed ID: 29029287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
    Maniakas A; Dadu R; Busaidy NL; Wang JR; Ferrarotto R; Lu C; Williams MD; Gunn GB; Hofmann MC; Cote G; Sperling J; Gross ND; Sturgis EM; Goepfert RP; Lai SY; Cabanillas ME; Zafereo M
    JAMA Oncol; 2020 Sep; 6(9):1397-1404. PubMed ID: 32761153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.